Liposarcoma

Also known as: Liposarcoma (morphologic abnormality) / Liposarcoma NOS / Liposarcomas malignant / Liposarcoma (disorder)

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00531	Cyclophosphamide	1	Not Yet Recruiting	1
DB08871	Eribulin	1	Active Not Recruiting	1
DB00530	Erlotinib	1	Recruiting	1
DB01073	Fludarabine	1	Not Yet Recruiting	1
DB00947	Fulvestrant	1	Withdrawn	1
DB15149	Futibatinib	1	Recruiting	1
DB00441	Gemcitabine	1	Completed	1
DB09570	Ixazomib	1	Withdrawn	1
DB11730	Ribociclib	1	Completed	1
DB11942	Selinexor	1	Withdrawn	1
DB16331	Siremadlin	1	Completed	1
DB05109	Trabectedin	1	Completed	1
DB17549	Alrizomadlin	1 / 2	Recruiting	1
DB14707	Cemiplimab	1 / 2	Recruiting	1
DB01248	Docetaxel	1 / 2	Recruiting	1
DB00997	Doxorubicin	1 / 2	Recruiting	1
DB08899	Enzalutamide	1 / 2	Recruiting	1
DB08871	Eribulin	1 / 2	Active Not Recruiting	1
DB00947	Fulvestrant	1 / 2	Recruiting	1
DB01181	Ifosfamide	1 / 2	Recruiting	1
DB09078	Lenvatinib	1 / 2	Active Not Recruiting	1
DB01006	Letrozole	1 / 2	Recruiting	1
DB00683	Midazolam	1 / 2	Recruiting	1
DB06589	Pazopanib	1 / 2	Recruiting	1
DB11942	Selinexor	1 / 2	Recruiting	1
DB15043	Toripalimab	1 / 2	Recruiting	1
DB05109	Trabectedin	1 / 2	Recruiting	1
DB11595	Atezolizumab	2	Terminated	1
DB00112	Bevacizumab	2	Completed	1
DB03619	Deoxycholic acid	2	Terminated	1
DB01234	Dexamethasone	2	Completed	1
DB00380	Dexrazoxane	2	Completed	1
DB01248	Docetaxel	2	Withdrawn	2
DB00997	Doxorubicin	2	Completed	1
DB00997	Doxorubicin	2	Not Yet Recruiting	1
DB11894	Efatutazone	2	Completed	1
DB16047	Elraglusib	2	Withdrawn	2
DB08871	Eribulin	2	Active Not Recruiting	1
DB17292	G305	2	Terminated	1
DB00441	Gemcitabine	2	Withdrawn	2
DB01181	Ifosfamide	2	Not Yet Recruiting	1
DB17288	LV305	2	Terminated	1
DB09073	Palbociclib	2	Completed	1
DB06589	Pazopanib	2	Completed	1
DB09037	Pembrolizumab	2	Active Not Recruiting	1
DB08896	Regorafenib	2	Completed	1
DB11730	Ribociclib	2	Unknown Status	1
DB06233	Ridaforolimus	2	Completed	1
DB15036	Sitravatinib	2	Active Not Recruiting	1
DB01268	Sunitinib	2	Completed	1
DB13896	Talimogene laherparepvec	2	Active Not Recruiting	1
DB05109	Trabectedin	2	Completed	2
DB00531	Cyclophosphamide	2 / 3	Active Not Recruiting	1
DB00694	Daunorubicin	2 / 3	Active Not Recruiting	1
DB00997	Doxorubicin	2 / 3	Active Not Recruiting	1
DB01181	Ifosfamide	2 / 3	Active Not Recruiting	1
DB06589	Pazopanib	2 / 3	Active Not Recruiting	1
DB05109	Trabectedin	3	Withdrawn	1